The Effects of Methylphenidate on Cognitive Function in Children with Attention–Deficit/Hyperactivity Disorder

2012 ◽  
Vol 124 (5) ◽  
pp. 33-48 ◽  
Author(s):  
Hanna A. Kubas ◽  
Erica M. Backenson ◽  
Gabrielle Wilcox ◽  
Jamie C. Piercy ◽  
James B. Hale
2018 ◽  
Vol 19 ◽  
pp. 374-383 ◽  
Author(s):  
Kuaikuai Duan ◽  
Jiayu Chen ◽  
Vince D. Calhoun ◽  
Dongdong Lin ◽  
Wenhao Jiang ◽  
...  

2015 ◽  
Vol 26 ◽  
pp. 227-240 ◽  
Author(s):  
Esther Aarts ◽  
Mieke van Holstein ◽  
Martine Hoogman ◽  
Marten Onnink ◽  
Cornelis Kan ◽  
...  

2020 ◽  
Vol 27 (1) ◽  
Author(s):  
Gellan K. Ahmed ◽  
Alaa M. Darwish ◽  
Hossam Khalifa ◽  
Mohamed A. Khashbah

Abstract Background Epilepsy is one of the most common neurological conditions. Attention deficit hyperactivity disorder (ADHD) in children with epilepsy proves to be very common. Both epilepsy and ADHD impair quality of life. We aimed to evaluate cognitive function, socioeconomic level, and quality of life (QOL) among children with ADHD and epilepsy. A total of 100 children were divided into 5 groups (20 children/group) as (I) epilepsy, (II) ADHD with epilepsy, (III) ADHD with EEG changes, (IV) ADHD without EEG changes, and (V) control. Children aged between 6 and 11 years were recruited for this study. Early Childhood Epilepsy Severity Scale (E-Chess), Conners’ Parent Rating Scale (CPRS), Wechsler Intelligence Scale for Children-3rd edition (WISC-III), socioeconomic scale for assessment of social burden and socioeconomic classes, and PedsQL (quality of life measure) assessed. Results Children with ADHD and epilepsy had the lowest PedsQL total scores and lower scores than other groups especially in performance IQ score. The highest percentage of low socioeconomic class (25%) was observed in the group of ADHD with epilepsy and the group of epilepsy. Conclusion ADHD with epilepsy is associated with low performance IQ, poor socioeconomic level, and quality of life. Pediatric Quality of Life Inventory scores show significant correlation with total IQ score in the group of ADHD with epilepsy.


PEDIATRICS ◽  
1992 ◽  
Vol 89 (2) ◽  
pp. 351-351
Author(s):  
ROBERT G. VOIGT ◽  
GRAEME H. JOHNSON ◽  
FRANK R. BROWN

To the Editor.— This letter cautions the general practitioner about prescribing methylphenidate to children with mental retardation, despite the reported utility in nine patients.1 Methylphenidate is understood to be an effective medication for treatment of children who have attention-deficit hyperactivity disorder (ADHD), characterized by a developmentally inappropriate attention span, level of impulsiveness, and motor activity. For the general practitioner, ADHD typically is identified in children with normal neurodevelopment. Because children with mental retardation may have attention spans, impulse control, and activity levels inappropriate for their chronologic age, albeit appropriate for their underlying level of cognitive function, we are concerned about the general practitioner's ability to identify ADHD in children with mental retardation.


Sign in / Sign up

Export Citation Format

Share Document